Home » Topics » Regulatory

Regulatory
RSS

Topical formulations of CMI-392, a dual PAF antagonist and 5-LO inhibitor

June 1, 2000

FDA approves Relenza for treatment of pediatric influenza; E.U. prophylaxis filing updated

May 31, 2000

PEG-Intron monotherapy approved for HCV in E.U.

May 31, 2000

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

Clonidine may help reduce tamoxifen-induced hot flashes in breast cancer patients

May 29, 2000

Roche files for new Tamiflu indication with FDA

May 26, 2000

Use of verteporfin for improving xenograft transplant survival

May 26, 2000

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Amitriptyline demonstrates potential for use in IBS at low doses

May 24, 2000

Adolor patents use of peripherally acting opiates for pruritus

May 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...